Equities research analysts expect that Express Scripts Holding Co (NASDAQ:ESRX) will post earnings per share of $2.42 for the current fiscal quarter, according to Zacks. Nine analysts have provided estimates for Express Scripts’ earnings, with the highest EPS estimate coming in at $2.43 and the lowest estimate coming in at $2.40. Express Scripts posted earnings of $1.90 per share in the same quarter last year, which would indicate a positive year-over-year growth rate of 27.4%. The business is expected to issue its next quarterly earnings report after the market closes on Wednesday, October 31st.
According to Zacks, analysts expect that Express Scripts will report full-year earnings of $9.07 per share for the current financial year, with EPS estimates ranging from $9.00 to $9.10. For the next financial year, analysts expect that the company will report earnings of $9.46 per share, with EPS estimates ranging from $9.05 to $10.15. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research analysts that follow Express Scripts.
Express Scripts (NASDAQ:ESRX) last issued its quarterly earnings results on Wednesday, August 1st. The company reported $2.22 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.20 by $0.02. Express Scripts had a net margin of 4.65% and a return on equity of 25.49%. The company had revenue of $25.64 billion during the quarter, compared to analyst estimates of $25.43 billion. During the same quarter last year, the business posted $1.73 EPS. Express Scripts’s quarterly revenue was up 1.2% compared to the same quarter last year.
ESRX has been the subject of several research analyst reports. BidaskClub lowered shares of Express Scripts from a “hold” rating to a “sell” rating in a research note on Saturday, July 21st. ValuEngine upgraded shares of Express Scripts from a “hold” rating to a “buy” rating in a research note on Monday, September 17th. Credit Suisse Group lowered shares of Express Scripts from an “outperform” rating to a “neutral” rating and raised their price target for the stock from $90.00 to $96.50 in a research note on Tuesday, September 18th. Zacks Investment Research lowered shares of Express Scripts from a “hold” rating to a “sell” rating in a research note on Monday, July 23rd. Finally, William Blair upgraded shares of Express Scripts from a “market perform” rating to an “outperform” rating in a research note on Wednesday, August 1st. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. The company has an average rating of “Hold” and an average target price of $86.36.
In related news, insider Christine Houston sold 12,898 shares of Express Scripts stock in a transaction that occurred on Friday, August 10th. The shares were sold at an average price of $85.00, for a total value of $1,096,330.00. Following the completion of the transaction, the insider now directly owns 110,908 shares in the company, valued at approximately $9,427,180. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.79% of the stock is currently owned by insiders.
A number of institutional investors have recently added to or reduced their stakes in the stock. Harvey Investment Co. LLC bought a new position in Express Scripts in the 3rd quarter valued at $233,000. Texas Permanent School Fund boosted its holdings in Express Scripts by 4.6% in the 3rd quarter. Texas Permanent School Fund now owns 143,335 shares of the company’s stock valued at $13,618,000 after purchasing an additional 6,261 shares during the period. IFM Investors Pty Ltd boosted its holdings in Express Scripts by 15.8% in the 3rd quarter. IFM Investors Pty Ltd now owns 29,622 shares of the company’s stock valued at $2,814,000 after purchasing an additional 4,044 shares during the period. West Coast Financial LLC bought a new position in Express Scripts in the 3rd quarter valued at $256,000. Finally, First Citizens Bank & Trust Co. boosted its holdings in Express Scripts by 500.6% in the 3rd quarter. First Citizens Bank & Trust Co. now owns 27,860 shares of the company’s stock valued at $2,647,000 after purchasing an additional 23,221 shares during the period. Institutional investors and hedge funds own 84.76% of the company’s stock.
Shares of ESRX stock opened at $94.99 on Friday. The company has a quick ratio of 0.59, a current ratio of 0.71 and a debt-to-equity ratio of 0.69. Express Scripts has a 12-month low of $58.23 and a 12-month high of $97.22. The company has a market cap of $53.57 billion, a PE ratio of 11.84, a P/E/G ratio of 1.20 and a beta of 1.01.
Express Scripts Company Profile
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
See Also: How is inflation measured?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.